Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Opportunities for immunotherapy in childhood acute myeloid leukemia

Adam J. Lamble, Sarah K. Tasian

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 218–225.

https://doi.org/10.1182/hematology.2019000357

Published: 2019

Journal Articles

New advances in the diagnosis of von Willebrand disease

Ruchika Sharma, Sandra L. Haberichter

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 596–600.

https://doi.org/10.1182/hematology.2019000064

Published: 2019

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.

https://doi.org/10.1182/hematology.2019000370

Published: 2019

Journal Articles

Mechanisms of and approaches to overcoming resistance to immunotherapy

Liora Schultz, Rebecca Gardner

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 226–232.

https://doi.org/10.1182/hematology.2019000018

Published: 2019

Journal Articles

Are CAR T cells better than antibody or HCT therapy in B-ALL?

Michael A. Pulsipher

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 16–24.

https://doi.org/10.1182/asheducation-2018.1.16

Published: 2018

Journal Articles

Shifting ground and gaps in transfusion support of patients with hematological malignancies

Christine Cserti-Gazdewich

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 553–560.

https://doi.org/10.1182/asheducation-2018.1.553

Published: 2018

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Developing T-cell therapies for lymphoma without receptor engineering

Melanie Grant, Catherine M. Bollard

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 622–631.

https://doi.org/10.1182/asheducation-2017.1.622

Published: 2017

Journal Articles

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Andrew C. Dietz, Alan S. Wayne

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 708–715.

https://doi.org/10.1182/asheducation-2017.1.708

Published: 2017

Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.

https://doi.org/10.1182/asheducation-2017.1.693

Published: 2017

Journal Articles

Cellular immune responses in red blood cell alloimmunization

James C. Zimring, Krystalyn E. Hudson

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 452–456.

https://doi.org/10.1182/asheducation-2016.1.452

Published: 2016

Journal Articles

Understanding red blood cell alloimmunization triggers

Jeanne E. Hendrickson, Christopher A. Tormey

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 446–451.

https://doi.org/10.1182/asheducation-2016.1.446

Published: 2016

Journal Articles

Cellular and vaccine immunotherapy for multiple myeloma

Alfred L. Garfall, Edward A. Stadtmauer

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 521–527.

https://doi.org/10.1182/asheducation-2016.1.521

Published: 2016

Journal Articles

What have we learned from large population studies of von Willebrand disease?

Robert R. Montgomery, Veronica H. Flood

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 670–677.

https://doi.org/10.1182/asheducation-2016.1.670

Published: 2016

Journal Articles

The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia

Daniel J. DeAngelo

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 400–405.

https://doi.org/10.1182/asheducation-2015.1.400

Published: 2015

Journal Articles

Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis

Carl E. Allen, Kenneth L. McClain

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 177–182.

https://doi.org/10.1182/asheducation-2015.1.177

Published: 2015

Journal Articles

Antigen-specific immunotherapies for acute myeloid leukemia

Sarah A. Buckley, Roland B. Walter

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 584–595.

https://doi.org/10.1182/asheducation-2015.1.584

Published: 2015

Journal Articles

Chimeric antigen receptor T-cell therapy for ALL

Shannon L. Maude, Elizabeth J. Shpall, Stephan A. Grupp

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 559–564.

https://doi.org/10.1182/asheducation-2014.1.559

Published: 2014

Journal Articles

Cytotoxic T lymphocytes for leukemia and lymphoma

Catherine M. Bollard, A. John Barrett

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 565–569.

https://doi.org/10.1182/asheducation-2014.1.565

Published: 2014

NARROW

Opportunities for immunotherapy in childhood acute myeloid leukemia

New advances in the diagnosis of von Willebrand disease

Myeloma: next generation immunotherapy

CAR T-cell therapy: is it prime time in myeloma?

Mechanisms of and approaches to overcoming resistance to immunotherapy

Are CAR T cells better than antibody or HCT therapy in B-ALL?

Shifting ground and gaps in transfusion support of patients with hematological malignancies

Antibody-based therapies in patients with acute lymphoblastic leukemia

Developing T-cell therapies for lymphoma without receptor engineering

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Graft versus tumor effects and why people relapse

Cellular immune responses in red blood cell alloimmunization

Understanding red blood cell alloimmunization triggers

Cellular and vaccine immunotherapy for multiple myeloma

What have we learned from large population studies of von Willebrand disease?

The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia

Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis

Antigen-specific immunotherapies for acute myeloid leukemia

Chimeric antigen receptor T-cell therapy for ALL

Cytotoxic T lymphocytes for leukemia and lymphoma

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only